Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Research works printed but not linked: 8
- 2004, Panminerva Med., 46, 61
- 2000, Cancer Res., 60, 1254
- 1999, Cancer Res., 59, 5002
- 2004, Blood., 105, 1815
- 2004, Blood., 104, 1217
- 1993, Cancer Biol., 4, 231
- 2003, Cancer Cell Int., 3, 17
- 2003, Cancer Res., 63, 5821
Cited by
Items 101–200 of 747
Ayuzawa, R., Doi, C., Rachakatla, R. S., Pyle, M. M., Maurya, D. K., Troyer, D., & Tamura, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.011 · Cited by 133
Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?
Charytonowicz, E., Cordon‐Cardo, C., Matushansky, I., & Ziman, M. R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.039 · Cited by 132
Tang, Y., Cai, B., Yuan, F., He, X., Lin, X., Wang, J., Wang, Y., & Yang, G.-Y. (2014) · Cell Transplantation · doi:10.3727/096368913x667510 · Cited by 131
Immunomodulatory Effect of Mesenchymal Stromal Cells: Possible Mechanisms
Nasef, A., Ashammakhi, N. A., & Fouillard, L. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.4.531 · Cited by 136
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008) · Cytotherapy · doi:10.1080/14653240802486517 · Cited by 128
Wise, A. F., Williams, T. M., Kiewiet, M. B. G., Payne, N. L., Siatskas, C., Samuel, C. S., & Ricardo, S. D. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00675.2013 · Cited by 127
Faustini, M., Bucco, M., Chlapanidas, T., Lucconi, G., Marazzi, M., Tosca, M. C., Gaetani, P., Klinger, M., Villani, S., Ferretti, V. V., et al. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0214 · Cited by 126
The therapeutic potential of mesenchymal stem cells: Cell- & Tissue-based Therapy
Picinich, S. C., Mishra, P. J., Mishra, P. J., Glod, J., & Banerjee, D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.965 · Cited by 123
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation
Li, J., Ezzelarab, M. B., & Cooper, D. K. C. (2012) · Xenotransplantation · doi:10.1111/xen.12000 · Cited by 134
Ganta, C., Chiyo, D., Ayuzawa, R., Rachakatla, R., Pyle, M., Andrews, G., Weiss, M., Tamura, M., & Troyer, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2750 · Cited by 122
The Wnt Signal Transduction Pathway in Stem Cells and Cancer Cells: Influence on Cellular Invasion
Neth, P., Ries, C., Karow, M., Egea, V., Ilmer, M., & Jochum, M. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0001-y · Cited by 134
Pati, S., Khakoo, A. Y., Zhao, J., Jiménez, F., Gerber, M. H., Harting, M. T., Redell, J. B., Grill, R. J., Matsuo, Y., Guha, S., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0013 · Cited by 137
Self-citationSafety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
Perrot, P., Rousseau, J., Bouffaut, A.-L., Rédini, F., Cassagnau, E., Deschaseaux, F., Heymann, M.-F., Heymann, D., Duteille, F., Trichet, V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010999 · Cited by 120
Zuccarini, M., Giuliani, P., Ziberi, S., Carluccio, M., Iorio, P. D., Caciagli, F., & Ciccarelli, R. (2018) · Genes · doi:10.3390/genes9020105 · Cited by 129
Genetically modified mesenchymal stromal cells in cancer therapy
Sage, E. K., Thakrar, R. M., & Janes, S. M. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.09.003 · Cited by 119
Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad
Mohseny, A. B., & Hogendoorn, P. C. W. (2011) · Stem Cells · doi:10.1002/stem.596 · Cited by 142
Recent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
Role of MSC in the Tumor Microenvironment
Hass, R. (2020) · Cancers · doi:10.3390/cancers12082107 · Cited by 116
“In this context, the application of human MSC in an in vivo model of Kaposi’s sarcoma induced tumor-suppressive effects [98], which underscores the variable pro-tumorigenic and anti-tumorigenic effects of MSC.”
BackgroundLjujic, B., Milovanovic, M., Volarevic, V., Murray, B., Bugarski, D., Przyborski, S., Arsenijevic, N., Lukic, M. L., & Stojkovic, M. (2013) · Scientific Reports · doi:10.1038/srep02298 · Cited by 115
Advances in mesenchymal stem cell-mediated gene therapy for cancer
Dwyer, R. M., Khan, S., Barry, F. P., O'Brien, T., & Kerin, M. J. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt25 · Cited by 115
Mesenchymal Stem Cells in Tissue Growth and Repair
Kalinina, N., Sysoeva, V., Rubina, K. A., Parfenova, Y. V., & Va, T. (2011) · Acta Naturae · doi:10.32607/20758251-2011-3-4-30-37 · Cited by 124
Zhao, W., Qin, P., Zhang, D., Cui, X., Gao, J., Yu, Z., Chai, Y., Wang, J., & Li, J. (2019) · Aging · doi:10.18632/aging.102406 · Cited by 115
“For instance, the direct contact of BMSC with tumor cell inhibits tumor growth in Kaposi’s sarcoma [23]; the combination treatment of TRAIL-expressing BMSCs with doxorubicin promotes breast cancer apoptosis in vitro and tumor suppression in vivo [24].”
BackgroundNanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers
Kaneti, L., Bronshtein, T., Malkah Dayan, N., Kovregina, I., Letko Khait, N., Lupu-Haber, Y., Fliman, M., Schoen, B. W., Kaneti, G., & Machluf, M. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b04237 · Cited by 113
Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach
Adjei, I. M., & Sharma, B. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6010081 · Cited by 132
Immunophenotype characterization of rat mesenchymal stromal cells
Harting, M. T., Jiménez, F., Pati, S., Baumgartner, J. A., & Cox, C. S. (2008) · Cytotherapy · doi:10.1080/14653240801950000 · Cited by 110
Self-citationStem cells as vectors for antitumour therapy
Loebinger, M. R., & Janes, S. M. (2010) · Thorax · doi:10.1136/thx.2009.128025 · Cited by 109
“Furthermore, intravenously delivered MSCs were able to inhibit the growth of KS in a mouse model due to cellecell contact-induced inhibition of Akt activity within KS cells.(13) The release of soluble factors by MSCs has also been shown to reduce tumour growth and progression in glioma,(48) melanoma and lung carcinoma…”
BackgroundLindoso, R. S., Collino, F., & Camussi, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3503 · Cited by 120
Xu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K., & Van Riet, I. (2012) · Stem Cells · doi:10.1002/stem.787 · Cited by 103
N. Momin, E., Vela, G., A. Zaidi, H., & Quinones-Hinojosa, A. (2010) · Current Immunology Reviews · doi:10.2174/157339510791111718 · Cited by 103
Toward Brain Tumor Gene Therapy Using Multipotent Mesenchymal Stromal Cell Vectors
Bexell, D., Scheding, S., & Bengzon, J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.58 · Cited by 107
The Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis
Schweizer, R., Tsuji, W., Gorantla, V. S., Marra, K. G., Rubin, J. P., & Plock, J. A. (2015) · Stem Cells International · doi:10.1155/2015/120949 · Cited by 110
Ryu, H., Oh, J.-E., Rhee, K., Baik, S. K., Kim, J., Kang, S. J., Sohn, J. H., Choi, E. H., Shin, H. C., Kim, Y. M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.018 · Cited by 110
Potential implications of mesenchymal stem cells in cancer therapy
Dai, L.-J., Moniri, M. R., Zeng, Z.-R., Zhou, J. X., Rayat, J., & Warnock, G. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.012 · Cited by 99
Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance
Xuan, X., Tian, C., Zhao, M., Sun, Y., & Huang, C. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02300-4 · Cited by 109
Mohr, A., Albarenque, S. M., Deedigan, L., Yu, R., Reidy, M., Fulda, S., & Zwacka, R. M. (2010) · Stem Cells · doi:10.1002/stem.533 · Cited by 97
Cortini, M., Massa, A., Avnet, S., Bonuccelli, G., & Baldini, N. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166500 · Cited by 97
Rossignoli, F., Caselli, A., Grisendi, G., Piccinno, M. S., Burns, J. S., Murgia, A., Veronesi, E., Loschi, P., Masini, C., Conte, P., et al. (2013) · BioMed Research International · doi:10.1155/2013/901821 · Cited by 104
Potter, D. R., Miyazawa, B. Y., Gibb, S. L., Deng, X., Togarrati, P. P., Croze, R. H., Srivastava, A. K., Trivedi, A. A., Matthay, M. A., Holcomb, J. B., et al. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001744 · Cited by 101
Self-citationLi, W., Liu, Q., Shi, J., Xu, X. M., & Xu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074863 · Cited by 131
Altanerová, V., Cihova, M., Babič, M., Rychlý, B., Ondičová, K., Mravec, B., & Altaner, Č. (2011) · International Journal of Cancer · doi:10.1002/ijc.26278 · Cited by 100
Regenerative therapy after cancer: what are the risks?
Donnenberg, V. S., Zimmerlin, L., Rubin, J. P., & Donnenberg, A. D. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2010.0352 · Cited by 95
Mirzaei, H., Sahebkar, A., Avan, A., R. Jaafari, M., Salehi, R., Salehi, H., Baharvand, H., Rezaei, A., Hadjati, J., M. Pawelek, J., et al. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666151217122033 · Cited by 94
The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth
Han, Z., Jing, Y., Zhang, S., Liu, Y., Shi, Y., & Wei, L. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-8 · Cited by 101
Mesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
Gao, Y., Yao, A., Zhang, W., Lu, S., Yu, Y., Deng, L., Yin, A., Xia, Y., Sun, B., & Wang, X. (2010) · Oncogene · doi:10.1038/onc.2010.38 · Cited by 93
Kim, R., Lee, S., Lee, J., Kim, M., Kim, W. J., Lee, H. W., Lee, M. Y., Kim, J., & Chang, W. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.8.105 · Cited by 89
Mesenchymal Stem Cells Beyond Regenerative Medicine
Shammaa, R., El-Kadiry, A. E.-H., Abusarah, J., & Rafei, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00072 · Cited by 92
Mesenchymal Stem Cells in Cancer
Stagg, J. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9030-4 · Cited by 103
Liu, X., Wu, M., Peng, Y., Chen, X., Sun, J., Huang, F., Fan, Z., Zhou, H., Wu, X., Yu, G., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x661319 · Cited by 93
Xia, Y., Zhu, J., Yang, R., Wang, H., Li, Y., & Fu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1141601 · Cited by 87
Yamada, K., Uchiyama, A., Uehara, A., Perera, B., Ogino, S., Yokoyama, Y., Takeuchi, Y., Udey, M. C., Ishikawa, O., & Motegi, S.-I. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2812 · Cited by 87
Dwyer, R. M., Ryan, J., Havelin, R. J., Morris, J. C., Miller, B. W., Liu, Z., Flavin, R., O'Flatharta, C., Foley, M. J., Barrett, H. H., et al. (2011) · STEM CELLS · doi:10.1002/stem.665 · Cited by 86
Layek, B., Sadhukha, T., & Prabha, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.024 · Cited by 92
Kang, N.-H., Hwang, K.-A., Kim, S. U., Kim, Y.-B., Hyun, S., Jeung, E.-B., & Choi, K.-C. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.30 · Cited by 94
Magatti, M., Munari, S. D., Vertua, E., & Parolini, O. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01531.x · Cited by 85
Shojaei, S., Hashemi, S. M., Ghanbarian, H., Salehi, M., & Mohammadi‐Yeganeh, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27326 · Cited by 84
Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
Brennen, W. N., Chen, S., Denmeade, S. R., & Isaacs, J. T. (2012) · Oncotarget · doi:10.18632/oncotarget.805 · Cited by 92
Ma, Y., Hao, X., Zhang, S., & Zhang, J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1774-x · Cited by 85
Self-citationBian, Z., Fan, Q., Li, G., Xu, W., & Tang, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01731.x · Cited by 83
Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy
Leng, L., Wang, Y., He, N., Wang, D., Zhao, Q., Feng, G., Su, W., Xu, Y., Han, Z., Kong, D., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.014 · Cited by 83
Review of Mesenchymal Stem Cells and Tumors: Executioner or Coconspirator?
Feng, B., & Chen, L. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0652 · Cited by 83
“This anti-proliferative action has nothing to do with systemic immune responses and is dependent on the dose of MSCs. 9 Indeed, different doses of MSCs lead to different effects on tumor growth: A 10-fold enhancement of a tumor-suppresive MSCs dose might be tumor promoting, on the contrary.”
Li, X., Ling, W., Pennisi, A., Wang, Y., Khan, S., Heidaran, M., Pal, A., Zhang, X., He, S., Zeitlin, A., et al. (2011) · Stem Cells · doi:10.1002/stem.572 · Cited by 83
Abdel aziz, M. T., El Asmar, M. F., Atta, H. M., Mahfouz, S., Fouad, H. H., Roshdy, N. K., Rashed, L. A., Sabry, D., Hassouna, A. A., & Taha, F. M. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-49 · Cited by 83
Mesenchymal Stromal Cells for Transplant Tolerance
Podestà, M. A., Remuzzi, G., & Casiraghi, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01287 · Cited by 89
Mesenchymal stem cells and cancer: Friends or enemies?
Hong, I.-S., Lee, H.-Y., & Kang, K.-S. (2014) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2014.01.006 · Cited by 82
Therapeutic Implications of Mesenchymal Stem Cells in Liver Injury
Puglisi, M. A., Tesori, V., Lattanzi, W., Piscaglia, A. C., Gasbarrini, G. B., D′Ugo, D. M., & Gasbarrini, A. (2011) · BioMed Research International · doi:10.1155/2011/860578 · Cited by 81
Both human and mouse mesenchymal stem cells promote breast cancer metastasis
Albarenque, S. M., Zwacka, R. M., & Mohr, A. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.05.002 · Cited by 87
Lin, J., Wang, J., Chen, M., Chen, H.-C., Chang, T.-H., Su, B.-W., & Chang, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.003 · Cited by 91
Zhao, Y., Gibb, S. L., Zhao, J., Moore, A. N., Hylin, M. J., Menge, T. D., Xue, H., Baimukanova, G., Potter, D. R., Johnson, E. M., et al. (2016) · Stem Cells · doi:10.1002/stem.2310 · Cited by 83
Self-citationHuman mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Pacioni, S., D’Alessandris, Q. G., Giannetti, S., Morgante, L., Coccè, V., Bonomi, A., Buccarelli, M., Pascucci, L., Alessandri, G., Pessina, A., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0516-3 · Cited by 78
Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer
Tang, R., Shen, S., Zhao, X., Nie, Y., Xu, Y., Ren, J., Lv, M., Hou, Y., & Wang, T. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0055-8 · Cited by 81
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Kavianpour, M., Saleh, M., & Verdi, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01849-7 · Cited by 78
Hughes, R. M., Simons, B. W., Khan, H., Miller, R., Kugler, V., Torquato, S., Theodros, D., Haffner, M. C., Lotan, T., Huang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2931 · Cited by 75
Lim, E.-J., Kim, S., Oh, Y., Suh, Y., Kaushik, N., Lee, J.-H., Lee, H., Kim, M.-J., Park, M. J., Kim, R.-K., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa064 · Cited by 78
Han, Z., Tian, Z., Lv, G., Zhang, L., Jiang, G., Sun, K., Wang, C., Bu, X., Li, R., Shi, Y., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01215.x · Cited by 76
Escobar, P., Bouclier, C., Serret, J., Bièche, I., Brigitte, M., Caicedo, A., Sanchez, E., Vacher, S., Vignais, M., Bourin, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4732 · Cited by 82
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., Fuller, G. N., Goodman, L. D., Sulman, E. P., & Lang, F. F. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now239 · Cited by 85
Mesenchymal stromal cells as cancer promoters
Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75
Chang, D., Yoo, S., Hong, Y., Kim, S., Kim, S. J., Yoon, S., Cho, K., Paek, S. H., Lee, Y., Kim, S., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25383 · Cited by 75
Honda, M., Hori, Y., Nakada, A., Uji, M., Nishizawa, Y., Yamamoto, K., Kobayashi, T., Shimada, H., Kida, N., Satō, T., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.11.008 · Cited by 81
Zhou, S., Abdouh, M., Arena, V., Arena, M., & Arena, G. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169899 · Cited by 76
Balyasnikova, I. V., Ferguson, S. D., Sengupta, S., Han, Y., & Lesniak, M. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009750 · Cited by 77
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
Buitenhuis, M., Verhagen, L. P., van Deutekom, H. W. M., Castor, A., Verploegen, S. A. B. W., Koenderman, L., Jacobsen, S. E. W., & Coffer, P. J. (2007) · Blood · doi:10.1182/blood-2006-07-037572 · Cited by 83
Yin, Z., Jiang, K., Li, R., Dong, C., & Wang, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0926-6 · Cited by 73
The role of mesenchymal stem cells in cancer development
Yagi, H., & Kitagawa, Y. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00261 · Cited by 72
Kalimuthu, S., Gangadaran, P., Li, X. J., Oh, J. M., Lee, H., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2016) · Scientific Reports · doi:10.1038/srep30418 · Cited by 75
LI, T., ZHANG, C., DING, Y., ZHAI, W., LIU, K., BU, F., TU, T., SUN, L., ZHU, W., ZHOU, F., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4109 · Cited by 73
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Le Naour, A., Quemerais, C., Hamel, D., Fournié, J.-J., Couderc, B., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 72
Potential of Mesenchymal Stem Cell based application in Cancer.
Ramdasi, S., Sarang, S. A., & Viswanathan, C. (2015) · PubMed Central · Cited by 83
Luetzkendorf, J., Mueller, L. P., Mueller, T., Caysa, H., Nerger, K., & Schmoll, H. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00794.x · Cited by 72
Menge, T. D., Gerber, M. H., Wataha, K. A., Reid, W. C., Guha, S., Cox, C. S., Dash, P. K., Reitz, M. S., Khakoo, A. Y., & Pati, S. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0165 · Cited by 77
Self-citationDoxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
Baxter-Holland, M., & Dass, C. R. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12869 · Cited by 80
Mele, V., Muraro, M. G., Calabrese, D., Pfaff, D., Amatruda, N., Amicarella, F., Kvinlaug, B., Bocelli‐Tyndall, C., Martin, I., Resink, T. J., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28598 · Cited by 71
Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses
Hadryś, A., Sochanik, A., McFadden, G., & Jazowiecka-Rakus, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172991 · Cited by 76
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Darestani, N. G., Rudova, A., Al-Gazally, M. E., Zekiy, A. O., Ansari, M. J., Zabibah, R. S., Jawad, M. A., Al-Shalah, S. A. J., Rizaev, J. A., Alnassar, Y. S., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01012-0 · Cited by 115
Aquino, J. B., Bolontrade, M. F., García, M. G., Podhajcer, O. L., & Mazzolini, G. D. (2010) · Gene Therapy · doi:10.1038/gt.2010.10 · Cited by 73
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
Brennen, W. N., Denmeade, S. R., & Isaacs, J. T. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0151 · Cited by 80
Belmar-Lopez, C., Mendoza, G., Oberg, D., Burnet, J., Simon, C., Cervello, I., Iglesias, M., Ramirez, J. C., Lopez-Larrubia, P., Quintanilla, M., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-139 · Cited by 71
The role and prospect of JMJD3 in stem cells and cancer
Yin, X., Yang, S., Zhang, M., & Yue, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109384 · Cited by 74
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.